News and Trends 28 Jan 2025
ITM-11 succeeds in phase 3: The first big win for radiopharma?
Discover ITM and its cancer candidate ITM-11, as it brings one of the first big wins the radiopharmaceutical sector awaits.
- Latest Posts
Best in Biotech 27 Jan 2025
Top 19 most-performing biotech stocks of 2024
Discover the top-performing biotech stocks in 2024 – from oncology to psychedelics some companies showed remarkable results.
In Depth 24 Jan 2025
Why are there only 20 cell and gene therapies in Europe?
There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem.
Podcast 24 Jan 2025
J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed
With Orca Bio’s CEO, Ivan Dimov,, we take a look at some of the highlights from the 43rd Annual J.P. Morgan Healthcare Conference
In Depth 23 Jan 2025
mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics
In this review of RNA therapies, we paint an overview of what’s going on in a field that could address a number of diseases.
Best in Biotech 22 Jan 2025
Curing ALS? Sixteen companies developing new treatments in 2025
Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 21 Jan 2025
14 biotech podcasts to tune into in 2025
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.
In Depth 20 Jan 2025
Is biotech M&A set to surge in 2025?
There is big hope for biotech M&A in 2025, with a resounding sense that activity will rise again as several important factors come into play.
In Depth 17 Jan 2025
Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?
Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype?
Podcast 17 Jan 2025
Venture capital co-creation: The next big thing in biotech investment?
This week, we talked with Jessica Owen, co-founder of Initiate Ventures, a venture firm with an interesting dual model.
News and Trends 16 Jan 2025
Top biotech deals of December 2024
The month of December saw a variety of biotech deals take place to advance therapies across different stages in development.
Best in Biotech 16 Jan 2025
Ten first-in-class drugs on track for FDA approval in 2025
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025.
ADVERTISEMENT
